Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FDAWK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,772
Award facts
- Contract value 100% obligated
- $43,771.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $43,771.69 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL formulation. This non-competitive, firm fixed-price delivery order was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Cosentyx is a specialty biologic medication used primarily for treating inflammatory conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. This award reflects the company's ongoing capability to fulfill federal medical supply requirements through its established relationship with DLA, which is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards anticipated in the coming years.
Quick answers
Who was awarded contract SPE2DB25FDAWK?
SPE2DB25FDAWK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FDAWK worth?
The government has obligated $43,772 on SPE2DB25FDAWK.
Is contract SPE2DB25FDAWK an order under another contract?
Yes. SPE2DB25FDAWK is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FDAWK competed?
The extent of competition for SPE2DB25FDAWK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award